Dr. Gerlai has published over 150 papers in peer reviewed scientific journals and books with a cumulative citation number over 6000 and an H index of 41. He is member of editorial boards of PLOS ONE, Genes Brain and Behaviour, Neurotoxicology and Teratology, he is Associate Editor of Frontiers in Genetics of Complex Traits, Review Editor for Frontiers in Neuroscience, Section Editor for BioMedCentral Neuroscience. He has edited several special issues of scientific journals and served as co-editor of handbooks on molecular genetic approaches in behavioural neuroscience. He has been serving as a scientific referee for more than 60 scientific journals and has been advising major grant funding agencies and refereed for multiple panels of the National Institutes of Health (NIH, USA), National Science Foundation (NSF, USA), Wellcome Trust (UK), Israeli Science Foundation, South Korean Science Foundation, the Natural Science and Engineering Research Council of Canada, and the Canadian Institutes of Health Research. He is founding member of the International Behavioral and Neural Genetics Society, IBANGS, was the treasurer and member-at-large of this Society. He was USA Councillor of the International Behavioral Neuroscience Society (IBNS) and has also served as Chair of several committees of IBNS. He has been a Fellow of IBNS since 2005 and he was the President of IBNS in 2007 and 2008. He received the Distinguished Scientist Award from IBANGS in 2013.
Dr. Gerlai’s research has been focussing on the biological and genetic mechanisms of behaviour. His current research at University of Toronto concerns behavioral phenotyping and forward genetic (mutagenesis) and psychopharmacological approaches with zebrafish to study such questions as the mechanisms of alcohol abuse and of learning and memory.